How much funding has Sweetch raised?

Sweetch has raised $23.5M in total funding, most recently a Series A round.

Who are Sweetch's investors?

Sweetch's investors include Entrée Capital, Philips, Tal Ventures, Noaber, Kortex Ventures, FinTLV.

Where is Sweetch headquartered?

Sweetch is headquartered in Tel Aviv, Israel.

What industry is Sweetch in?

Sweetch operates in Artificial Intelligence, Healthcare.

Sweetch

Your Trusted Voice for Chronic Condition Engagement

Tel Aviv, Israel · Founded 2013 · $23.5M raised

Artificial Intelligence

Healthcare

Headquarters: Tel Aviv
Employees: 11–50
Founded: 2013
Business Model: B2B2C

Website: sweetch.com
Total Funding: $23.5M
Last Round: $20.0M Series AJul 2021
Rounds: 2

About

Sweetch is an Israeli digital health company that has built the first fully automated precision engagement platform powered by AI and Emotional Intelligence. Its hyper-personalized engagement engine helps health ecosystem players including pharmaceutical companies, medical device manufacturers, payers, healthcare providers, and pharmacies build continuous, meaningful relationships with patients at scale. The platform leverages behavioral science and Just-in-Time Adaptive Intervention to deliver individualized recommendations across medication adherence, physical activity, weight management, nutrition, sleep, and mood. Sweetch addresses multiple chronic conditions including Type 2 diabetes, obesity, cardiovascular disease, autoimmune conditions, and oncology. Partners include Abbott, Dexcom, NovoCare, Bayer G4A, Roche, Philips, and Johns Hopkins University.

Summary

Sweetch is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2013. It has raised $23.5M in total across 2 rounds, most recently a $20.0M Series A round in Jul 2021. Investors include Entrée Capital, Philips and Tal Ventures.

LinkedIn X (Twitter)